Search Results - "Marcel Segbers"

Refine Results
  1. 1

    Variability in lutetium-177 SPECT quantification between different state-of-the-art SPECT/CT systems by Peters, Steffie M. B., Meyer Viol, Sebastiaan L., van der Werf, Niels R., de Jong, Nick, van Velden, Floris H. P., Meeuwis, Antoi, Konijnenberg, Mark W., Gotthardt, Martin, de Jong, Hugo W. A. M., Segbers, Marcel

    Published in EJNMMI physics (11-02-2020)
    “…Background Quantitative SPECT imaging in targeted radionuclide therapy with lutetium-177 holds great potential for individualized treatment based on dose…”
    Get full text
    Journal Article
  2. 2

    A dedicated paediatric [18F]FDG PET/CT dosage regimen by Cox, Christina P. W., van Assema, Daniëlle M. E., Verburg, Frederik A., Brabander, Tessa, Konijnenberg, Mark, Segbers, Marcel

    Published in EJNMMI research (19-07-2021)
    “…Background The role of 2-[ 18 F]fluoro-2-deoxy-D-glucose ([ 18 F]FDG) positron emission tomography/computed tomography (PET/CT) in children is still expanding…”
    Get full text
    Journal Article
  3. 3

    Towards standardization of absolute SPECT/CT quantification: a multi-center and multi-vendor phantom study by Peters, Steffie M. B., van der Werf, Niels R., Segbers, Marcel, van Velden, Floris H. P., Wierts, Roel, Blokland, Koos (J.) A. K., Konijnenberg, Mark W., Lazarenko, Sergiy V., Visser, Eric P., Gotthardt, Martin

    Published in EJNMMI physics (26-12-2019)
    “…Absolute quantification of radiotracer distribution using SPECT/CT imaging is of great importance for dosimetry aimed at personalized radionuclide precision…”
    Get full text
    Journal Article
  4. 4

    Intra-arterial PSMA injection using hepatic arterial infusion pump in intrahepatic cholangiocarcinoma: a proof-of-concept study by Veenstra, Mara Marieke Katrien, Vegt, Erik, Segbers, Marcel, Franssen, Stijn, Koerkamp, Bas Groot, Verburg, Frederik Anton, Thomeer, Maarten Guillaume Josephus

    Published in European radiology experimental (01-08-2024)
    “…Prostate-specific membrane antigen (PSMA) targeted tracers show increased uptake in several malignancies, indicating a potential for peptide radioligand…”
    Get full text
    Journal Article
  5. 5

    Standardized image quality for 68Ga-DOTA-TATE PET/CT by Cox, Christina P. W., Segbers, Marcel, Graven, Laura H., Brabander, Tessa, van Assema, Daniëlle M. E.

    Published in EJNMMI research (23-03-2020)
    “…Background Positron emission tomography (PET) imaging with 68 Gallium labeled somatostatin analogues ( 68 Ga-DOTA-SSA) plays a key role in neuroendocrine tumor…”
    Get full text
    Journal Article
  6. 6

    Reduction of [68Ga]Ga-DOTA-TATE injected activity for digital PET/MR in comparison with analogue PET/CT by Cox, Christina P. W., Brabander, Tessa, Vegt, Erik, de Lussanet de la Sablonière, Quido G., Graven, Laura H., Verburg, Frederik A., Segbers, Marcel

    Published in EJNMMI physics (15-03-2024)
    “…Background New digital detectors and block-sequential regularized expectation maximization (BSREM) reconstruction algorithm improve positron emission…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Inter-comparison of quantitative imaging of lutetium-177 (177Lu) in European hospitals by Wevrett, Jill, Fenwick, Andrew, Scuffham, James, Johansson, Lena, Gear, Jonathan, Schlögl, Susanne, Segbers, Marcel, Sjögreen-Gleisner, Katarina, Solný, Pavel, Lassmann, Michael, Tipping, Jill, Nisbet, Andrew

    Published in EJNMMI physics (02-08-2018)
    “…Background This inter-comparison exercise was performed to demonstrate the variability of quantitative SPECT/CT imaging for lutetium-177 ( 177 Lu) in current…”
    Get full text
    Journal Article
  9. 9

    The Alzheimer's disease-related glucose metabolic brain pattern by Teune, Laura K, Strijkert, Fijanne, Renken, Remco J, Izaks, Gerbrand J, de Vries, Jeroen J, Segbers, Marcel, Roerdink, Jos B T M, Dierckx, Rudi A J O, Leenders, Klaus L

    Published in Current Alzheimer research (01-01-2014)
    “…[(18)F]fluorodeoxyglucose (FDG) PET imaging of the brain can be used to assist in the differential diagnosis of dementia. Group differences in glucose uptake…”
    Get more information
    Journal Article
  10. 10
  11. 11

    Tubarial salivary glands show a low relative contribution to functional salivary gland tissue mass by Ling, Sui wai, van der Veldt, Astrid, Segbers, Marcel, Luiting, Henk, Brabander, Tessa, Verburg, Frederik

    Published in Annals of nuclear medicine (01-11-2024)
    “…Background In 2021, the tubarial salivary glands (TSGs) were newly identified on prostate-specific membrane antigen (PSMA) positron emission…”
    Get full text
    Journal Article
  12. 12

    Diabetes and hypertension are related to amyloid-beta burden in the population-based Rotterdam Study by van Arendonk, Joyce, Neitzel, Julia, Steketee, Rebecca M E, van Assema, Daniëlle M E, Vrooman, Henri A, Segbers, Marcel, Ikram, M Arfan, Vernooij, Meike W

    Published in Brain (London, England : 1878) (05-01-2023)
    “…Higher vascular disease burden increases the likelihood of developing dementia, including Alzheimer's disease. Better understanding the association between…”
    Get full text
    Journal Article
  13. 13

    Diabetes and hypertension are related to amyloid-beta burden in the population-based Rotterdam Study by van Arendonk, Joyce, Neitzel, Julia, Steketee, Rebecca M. E., van Assema, Daniëlle M. E., Vrooman, Henri A., Segbers, Marcel, Ikram, M. Arfan, Vernooij, Meike W.

    Published in Brain (London, England : 1878) (12-11-2022)
    “…Abstract Higher vascular disease burden increases the likelihood of developing dementia, including Alzheimer’s disease. Better understanding the association…”
    Get full text
    Journal Article
  14. 14

    Evaluation of the tolerability and safety of 225AcAc-PSMA-I&T in patients with metastatic prostate cancer: a phase I dose escalation study by Ling, Sui Wai, van der Veldt, Astrid A M, Konijnenberg, Mark, Segbers, Marcel, Hooijman, Eline, Bruchertseifer, Frank, Morgenstern, Alfred, de Blois, Erik, Brabander, Tessa

    Published in BMC cancer (29-01-2024)
    “…Life expectancy of patients with metastatic castration-resistant prostate cancer (mCRPC) is still limited despite several systemic treatments. Within five…”
    Get full text
    Journal Article
  15. 15

    Diabetes and hypertension are associated with elevated beta‐amyloid burden: evidence from the prospective population‐based Rotterdam Study by van Arendonk, Joyce, Neitzel, Julia, Steketee, Rebecca M.E., van Assema, Daniëlle, Segbers, Marcel, Ikram, M. Arfan, Vernooij, Meike W.

    Published in Alzheimer's & dementia (01-12-2022)
    “…Background Higher vascular risk increases the likelihood of developing dementia. Better understanding the association between vascular risk and Alzheimer’s…”
    Get full text
    Journal Article
  16. 16

    Diabetes and hypertension are associated with elevated beta‐amyloid burden: evidence from the population‐based Rotterdam Study by Neitzel, Julia, van Arendonk, Joyce, Steketee, Rebecca M.E., van Assema, Daniëlle, Segbers, Marcel, Ikram, M. Arfan, Vernooij, Meike W.

    Published in Alzheimer's & dementia (01-12-2022)
    “…Background Higher vascular risk increases the likelihood of developing dementia. Better understanding the association between vascular risk and Alzheimer’s…”
    Get full text
    Journal Article
  17. 17

    68 Ga-PSMA PET/CT for Response Evaluation of 223 Ra Treatment in Metastatic Prostate Cancer by de Jong, Anouk C, Segbers, Marcel, Ling, Sui Wai, Graven, Laura H, Mehra, Niven, Hamberg, Paul, Brabander, Tessa, de Wit, Ronald, van der Veldt, Astrid A M

    Published in Journal of Nuclear Medicine (01-10-2023)
    “…CT and bone scintigraphy are not useful for response evaluation of bone metastases to Ra treatment in metastatic castration-resistant prostate cancer (mCRPC)…”
    Get full text
    Journal Article
  18. 18

    68Ga-PSMA PET/CT for Response Evaluation of 223Ra Treatment in Metastatic Prostate Cancer by de Jong, Anouk C, Segbers, Marcel, Ling, Sui, Graven, Laura H, Mehra, Niven, Hamberg, Paul, Brabander, Tessa, de Wit, Ronald, der Veldt, Astrid AM

    Published in The Journal of nuclear medicine (1978) (01-10-2023)
    “…CT and bone scintigraphy are not useful for response evaluation of bone metastases to 223Ra treatment in metastatic castration-resistant prostate cancer…”
    Get full text
    Journal Article
  19. 19

    Development of [225Ac]Ac-PSMA-I&T for Targeted Alpha Therapy According to GMP Guidelines for Treatment of mCRPC by Hooijman, Eline L., Chalashkan, Yozlem, Ling, Sui Wai, Kahyargil, Figen F., Segbers, Marcel, Bruchertseifer, Frank, Morgenstern, Alfred, Seimbille, Yann, Koolen, Stijn L. W., Brabander, Tessa, de Blois, Erik

    Published in Pharmaceutics (13-05-2021)
    “…Recently, promising results of the antitumor effects were observed in patients with metastatic castration-resistant prostate cancer treated with 177Lu-labeled…”
    Get full text
    Journal Article
  20. 20

    Evaluation of the tolerability and safety of [ 225 Ac]Ac-PSMA-I&T in patients with metastatic prostate cancer: a phase I dose escalation study by Ling, Sui Wai, van der Veldt, Astrid A M, Konijnenberg, Mark, Segbers, Marcel, Hooijman, Eline, Bruchertseifer, Frank, Morgenstern, Alfred, de Blois, Erik, Brabander, Tessa

    Published in BMC cancer (29-01-2024)
    “…Life expectancy of patients with metastatic castration-resistant prostate cancer (mCRPC) is still limited despite several systemic treatments. Within five…”
    Get full text
    Journal Article